SCHEMBL4669154

SCHEMBL4669154

CCOC(=O)C1=C(C)N=c2sc(=Cc3ccc(OC(C)=O)cc3)c(=O)n2C1c1ccccc1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 10/20 0.80
KMT2A Q03164 10/20 0.80
PTPN22 Q9Y2R2 5/20 0.80
ALDH1A1 P00352 2/20 0.75
SMN1; SMN2 Q16637 1/20 0.75
TNF P01375 1/20 0.71
IL6 P05231 1/20 0.71
DUSP3 P51452 6/20 0.69
PTPN7 P35236 5/20 0.69
POLB P06746 3/20 0.69
PTPN12 Q05209 3/20 0.69
BLM P54132 2/20 0.69
CACNA1B Q00975 2/20 0.69
APBA1 Q02410 2/20 0.69
L3MBTL1 Q9Y468 2/20 0.69
DNMT1 P26358 1/20 0.69
DUSP6 Q16828 2/20 0.68
NPSR1 Q6W5P4 1/20 0.67
MAPT P10636 1/20 0.67
HPGD P15428 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4669151 1.00 MEN1 (0.80) MEN1KMT2APTPN22ALDH1A1SMN1; SMN2
SCHEMBL4669368 0.96 PTPN22 (0.74) MEN1KMT2APTPN22ALDH1A1SMN1; SMN2
SCHEMBL4669366 0.96 PTPN22 (0.74) MEN1KMT2APTPN22ALDH1A1SMN1; SMN2
SCHEMBL13855923 0.92 MEN1 (0.79) MEN1KMT2APTPN22ALDH1A1SMN1; SMN2
SCHEMBL4668189 0.91 MEN1 (0.82) MEN1KMT2APTPN22ALDH1A1TNF
SCHEMBL4668190 0.91 MEN1 (0.82) MEN1KMT2APTPN22ALDH1A1TNF
SCHEMBL4669224 0.90 MAPT (0.68) MEN1KMT2APTPN22ALDH1A1SMN1; SMN2
SCHEMBL4669226 0.90 MAPT (0.68) MEN1KMT2APTPN22ALDH1A1SMN1; SMN2
SCHEMBL14104331 0.89 PTPN22 (0.66) MEN1KMT2APTPN22ALDH1A1SMN1; SMN2
SCHEMBL4669327 0.89 MEN1 (0.69) MEN1KMT2APTPN22ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2000140-A1 Use of derivatives of 3-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine or of 3-oxo-2,3-dihydro-5H-imidazolo[3,2-a]pyrimidine for the preparation of pharmaceutical compositions intended for the treatment of cancer INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2008-12-10 EP disclosed